Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES26 - Thymoma
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C2
- IASLC CME Accredited
- Type: Education Session
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Moderators:Joachim G.J.V. Aerts, David Waller
-
+
Session Moderator
16:50 - 17:00 | Presenter: Joachim G.J.V. Aerts
- Abstract
Loading... -
+
Session Moderator
16:50 - 17:00 | Presenter: David Waller
- Abstract
Loading... -
+
ES26.01 - Session Introduction
16:00 - 16:01 | Presenter: Joachim G.J.V. Aerts
- Abstract
Loading... -
+
ES26.02 - Session Introduction
16:01 - 16:02 | Presenter: David Waller
- Abstract
Loading... -
+
ES26.03 - Pathological Staging of Thymic Epithelial Tumors
16:02 - 16:14 | Presenter: Anja C Roden
- Abstract
Loading... -
+
ES26.04 - How to Implement Surgery in the Multimodality Therapy of Thymic Epithelial Tumors
16:14 - 16:26 | Presenter: Enrico Ruffini
- Abstract
Loading... -
+
ES26.05 - Risks and Options of IO Therapy in Thymic Epithelial Tumors
16:26 - 16:38 | Presenter: Chen Zhao
- Abstract
Loading... -
+
ES26.06 - Indications for Radiation Therapy
16:38 - 16:50 | Presenter: Anna Wrona
- Abstract
Loading... -
+
ES26.07 - Live Q&A
16:50 - 17:00
- Abstract
Loading...
-
+
ES27 - Joint Global Lung Cancer Coalition and International Association for the Study of Lung Cancer Session - Breaking Down Roadblocks to Lung Cancer Care in 2022
- 16:00 - 17:00
- 8/08/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Patient Advocacy
- Moderators:Carolyn Aldige, David Baldwin
-
+
Session Moderator
16:00 - 16:00 | Presenter: Carolyn Aldige
- Abstract
Loading... -
+
Session Moderator
16:00 - 16:00 | Presenter: David Baldwin
- Abstract
Loading... -
+
Session Moderator
16:52 - 17:00 | Presenter: Ugo Pastorino
- Abstract
Loading... -
+
ES27.01 - Session Introduction
16:00 - 16:01 | Presenter: Carolyn Aldige
- Abstract
Loading... -
+
ES27.02 - Session Introduction
16:01 - 16:02 | Presenter: Ugo Pastorino
- Abstract
Loading... -
+
ES27.02 - Session Introduction
16:01 - 16:02 | Presenter: David Baldwin
- Abstract
Loading... -
+
ES27.03 - Mitigating the Effects of COVID - How Does Lung Cancer Recover?
16:02 - 16:12 | Presenter: David Baldwin
- Abstract
Loading... -
+
ES27.04 - Lung Cancer Screening - From Pilots to Programs and the Effects of Patient Advocacy
16:12 - 16:22 | Presenter: Shani Shilo
- Abstract
Loading... -
+
ES27.05 - Lung Cancer Screening - From Pilots to Programs
16:22 - 16:32 | Presenter: Matthew Peters
- Abstract
Loading... -
+
ES27.06 - Lung Cancer Patient Experience - The Impact of COVID
16:32 - 16:42 | Presenter: Merel Hennink
- Abstract
Loading... -
+
ES27.07 - Optimising Telehealth for the Lung Cancer Patient
16:42 - 16:52 | Presenter: Lauren Pretorius
- Abstract
Loading... -
+
ES27.08 - Live Q&A
16:52 - 17:00
- Abstract
Loading...
-
+
MA11 - Optimization of Technologies for Lung Cancer Screening: Population Selection and Nodule Handling
- 16:00 - 17:00
- 8/08/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Mini Oral
- Track: Early Detection and Screening
- Moderators:Anna Kerpel-Fronius, Annemiek Snoeckx
-
+
Session Moderator
16:52 - 17:00 | Presenter: Anna Kerpel-Fronius
- Abstract
Loading... -
+
Session Moderator
16:52 - 17:00 | Presenter: Annemiek Snoeckx
- Abstract
Loading... -
+
MA11.01 - Session Introduction
16:00 - 16:01 | Presenter: Anna Kerpel-Fronius
- Abstract
Loading... -
+
MA11.02 - Session Introduction
16:01 - 16:02 | Presenter: Annemiek Snoeckx
- Abstract
Loading... -
+
MA11.03 - Updated Cost-Effectiveness Analysis of Lung Cancer Screening for Australia, Capturing Differences in the Impact of NELSON and NLST Outcomes
16:02 - 16:07 | Presenter: Preston Ngo
- Abstract
Loading... -
+
MA11.04 - Genetic Variants of HUNT Lung Cancer Model Improve Lung Cancer Risk Assessment Over Clinical Models
16:07 - 16:12 | Presenter: Olav Toai Duc Nguyen
- Abstract
Loading... -
+
MA11.05 - The Blood Proteome of Imminent Lung Cancer
16:12 - 16:17 | Presenter: Hana Zahed
- Abstract
Loading... -
+
MA11.06 - Discussant
16:17 - 16:27 | Presenter: Carole Ridge
- Abstract
Loading... -
+
MA11.07 - The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World
16:27 - 16:32 | Presenter: Stephen Lam
- Abstract
Loading... -
+
MA11.08 - Value of Computer Aided Diagnosis on Radiologists’ Workflow and Recommendation for Reporting Lung Cancer Screening LDCT
16:32 - 16:37 | Presenter: Ren Yuan
- Abstract
Loading... -
+
MA11.09 - Artificial Intelligence in Lung Cancer Screening: Accuracy and Predictive Value
16:37 - 16:42 | Presenter: Ricardo Sales Santos
- Abstract
Loading... -
+
MA11.10 - Discussant
16:42 - 16:52 | Presenter: Arjun Nair
- Abstract
Loading... -
+
MA11.11 - Live Q&A
16:52 - 17:00
- Abstract
Loading...
-
+
OA11 - Optimal Patient Selection for Local Therapy in Stage IV NSCLC
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
- Moderators:Pablo Munoz-Schuffenegger, Mariana Brandao
-
+
Session Moderator
16:12 - 16:22 | Presenter: Pablo Munoz-Schuffenegger
- Abstract
Loading... -
+
Session Moderator
16:12 - 16:22 | Presenter: Mariana Brandao
- Abstract
Loading... -
+
OA11.01 - Session Introduction
16:00 - 16:01 | Presenter: Pablo Munoz-Schuffenegger
- Abstract
Loading... -
+
OA11.02 - Session Introduction
16:01 - 16:02 | Presenter: Mariana Brandao
- Abstract
Loading... -
+
OA11.03 - Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Non-Small Cell Lung Cancer: A Marker of Better Prognosis
16:02 - 16:12 | Presenter: Peter Lee Zhan
- Abstract
Loading... -
+
OA11.04 - The Factors Associated With Reduced Risk of Progression in Patients With Oligometastatic NSCLC Treated With Local Ablative Radiotherapy
16:12 - 16:22 | Presenter: Gowoon Yang
- Abstract
Loading... -
+
OA11.05 - Treatment Strategies Based on Different Oligoprogressive Patterns after Immunotherapy Resistance in Advanced NSCLC
16:22 - 16:32 | Presenter: Shun Lu
- Abstract
Loading... -
+
OA11.06 - Sequencing of ctDNA Revealed Radiotherapeutic Efficacy and Prognosis in Non-small Cell Lung Cancer Patients with Brain Metastasis
16:32 - 16:42 | Presenter: Xiaorong Dong
- Abstract
Loading... -
+
OA11.07 - Discussant
16:42 - 16:52 | Presenter: Digambar Behera
- Abstract
Loading... -
+
OA11.08 - Live Q&A
16:52 - 17:00
- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Alessandra Curioni-Fontecedro, Kostas Syrigos
-
+
Session Moderator
16:52 - 17:00 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading... -
+
Session Moderator
16:52 - 17:00 | Presenter: Kostas Syrigos
- Abstract
Loading... -
+
OA12.01 - Session Introduction
16:00 - 16:01 | Presenter: Alessandra Curioni-Fontecedro
- Abstract
Loading... -
+
OA12.02 - Session Introduction
16:01 - 16:02 | Presenter: Kostas Syrigos
- Abstract
Loading... -
+
OA12.03 - Phase 2 Study Analysis of Talazoparib (TALA) Plus Temozolomide (TMZ) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
16:02 - 16:12 | Presenter: Jonathan Goldman
- Abstract
Loading... -
+
OA12.04 - Efficacy of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer after Chemo-Immunotherapy: A Phase 2 Trial.
16:12 - 16:22 | Presenter: Dwight H Owen
- Abstract
Loading... -
+
OA12.05 - Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer
16:22 - 16:32 | Presenter: Hossein Borghaei
- Abstract
Loading... -
+
OA12.06 - First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results
16:32 - 16:42 | Presenter: Charles M Rudin
- Abstract
Loading... -
+
OA12.07 - Discussant
16:42 - 16:52 | Presenter: Virginie Westeel
- Abstract
Loading... -
+
OA12.08 - Live Q&A
16:52 - 17:00
- Abstract
Loading...
-
+
P2.01 - Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Oligometastatic Disease
-
+
P2.01-01 - Association Between Clinical Outcomes and Local Treatment in Stage IV Non-small Cell Lung Cancer Patients With Single Extrathoracic Metastasis
Presenter: Seung Joon Kim- Abstract
Loading... -
+
P2.01-02 - Delivery of Concurrent Extracranial Stereotactic Body Radiotherapy With Osimertinib for Oligoprogressive EGFR Mutated Stage IV NSCLC
Presenter: Eyal Tsur- Abstract
Loading...
-
+
P2.02 - Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Chemotherapy
-
+
P2.02-01 - Value of Albumin-to-Globulin Ratio for Survival Prediction in Advanced Stage Non-Small Cell Lung Cancer Treated with Chemotherapy
Presenter: Chaichana Chantharakhit- Abstract
Loading... -
+
P2.02-02 - A Phase 2 Study of MLN4924 (Pevonedistat) in Combination with Carboplatin and Paclitaxel in Advanced NSCLC Previously Treated with Immunotherapy
Presenter: Ralph Linwood Millett- Abstract
Loading... -
+
P2.02-03 - A Phase II Study of Metformin with Pemetrexed/Carboplatin in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
Presenter: Saurav Verma- Abstract
Loading...
-
+
P2.03 - Metastatic Non-small Cell Lung Cancer - Palliative Radiotherapy
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Palliative Radiotherapy
-
+
P2.03-01 - Initial Biodistribution Data of ImmunoPET A Phase 0/1 Study Characterising PD-L1 with 89 Zr-Durvalumab (MEDI4736) PET/CT
Presenter: Fiona Hegi-Johnson- Abstract
Loading...
-
+
P2.04 - Nursing and Allied Health Professionals
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Nursing and Allied Health Professionals
-
+
P2.04-01 - Lung Cancer Patient Experience Survey from Twelfth Central and Eastern Europe Countries
Presenter: Andreja Sajnic- Abstract
Loading... -
+
P2.04-02 - Psychosocial Burdens in Cancer Caregivership, an Updated Overview
Presenter: Csaba László Dégi- Abstract
Loading... -
+
P2.04-03 - Perceptions and Knowledge of Electronic Smoking Devices among Patients with Solid Tumors and their Care-Givers
Presenter: Paolo Bironzo- Abstract
Loading... -
+
P2.04-05 - Is Opioid Use in the Management of Stage III Non-Small Cell Lung Cancer Patients Necessary?
Presenter: Ulrike Gorgens- Abstract
Loading...
-
+
P2.05 - Palliative and Supportive Care
- 17:15 - 19:15
- 8/08/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Palliative and Supportive Care
-
+
P2.05-01 - The Effect of Treadmill Training on Cardiopulmonary, Health-related Quality of Life in Lung Cancer with Lobectomy
Presenter: Kyung-Lim Joa- Abstract
Loading...
first
prev
